Bumper Offer - Urjas oil Just @ Rs. 1
StayHappi Glibenclamide + Metformin Tablet is an allopathic medicine The correct dosage of StayHappi Glibenclamide + Metformin Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Glibenclamide + Metformin Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when StayHappi Glibenclamide + Metformin Tablet is used -
Severe
Moderate
Mild
Common
Is the use of StayHappi Glibenclamide + Metformin Tablet safe for pregnant women?
StayHappi Glibenclamide + Metformin Tablet has little to no side effects in pregnant women.
Is the use of StayHappi Glibenclamide + Metformin Tablet safe during breastfeeding?
StayHappi Glibenclamide + Metformin Tablet may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking StayHappi Glibenclamide + Metformin Tablet, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of StayHappi Glibenclamide + Metformin Tablet.
What is the effect of StayHappi Glibenclamide + Metformin Tablet on the Kidneys?
Using StayHappi Glibenclamide + Metformin Tablet does not have any harmful effects on kidneys.
What is the effect of StayHappi Glibenclamide + Metformin Tablet on the Liver?
Using StayHappi Glibenclamide + Metformin Tablet does not have any harmful effects on the liver.
What is the effect of StayHappi Glibenclamide + Metformin Tablet on the Heart?
StayHappi Glibenclamide + Metformin Tablet is completely safe for the heart.
StayHappi Glibenclamide + Metformin Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Glibenclamide + Metformin Tablet unless your doctor advises you to do so -
Is this StayHappi Glibenclamide + Metformin Tablet habit forming or addictive?
No, you will not get addicted to StayHappi Glibenclamide + Metformin Tablet.
Interaction between Food and StayHappi Glibenclamide + Metformin Tablet
Due to the absence of research, it is difficult to say how StayHappi Glibenclamide + Metformin Tablet and food will interact.
Interaction between Alcohol and StayHappi Glibenclamide + Metformin Tablet
Consuming StayHappi Glibenclamide + Metformin Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826